Kerala Ayurveda Ltd (KAL) on Wednesday said the company has awarded its first patent for a uniquely processed proprietary herbal formulation, inspired by ancient ayurvedic wisdom from the United States Patent and Trademark Office (USPTO).
The company said in an exchange filing, said, “The product has been extensively studied through the rigours of modern scientific validation through phytochemical & marker analysis, extensive pre-clinical at renovel discoveries Inc in the United States and pharma rigour double-blind placebo-controlled clinical study at the well-known Banaras Hindu University (BHU) in India.”
The company claimed that the patent covers the efficacy of the herbal composition in the management of metabolic syndrome disorders such as Type 2 diabetes mellitus, obesity, and lipid profile management, as well as the use of the herbal composition in the preparation of food supplements, pharmaceuticals, and nutraceuticals in suitable dosage forms such as beverages/liquids, capsules, tablets, granules, jellies, and so on.
Also, the US-based Kerala Ayurveda Academy has opened its new branch in Norway. Kerala Ayurveda Academy was founded in 2006 and it offers authentic ayurvedic education (courses and treatments, approved by California and Washington States and the National Ayurvedic Medical Association).
Further, the company announced the opening of Ayurvedagram Bali, its new wellness resort in Indonesia. Located in the heart of Ubud, Ayurvedagram Bali is a 25-room resort nestled amongst 7,000 square meters of breathtaking scenery.
(Edited by : Sudarsanan Mani)
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Telangana Lok Sabha elections 2024: Asaduddin Owaisi to Bandi Sanjay Kumar, a look at key candidates
May 11, 2024 3:32 PM
Lok Sabha elections 2024: Hyderabad to Kadapa, key seats in fourth phase
May 11, 2024 2:54 PM
Telangana Lok Sabha elections 2024: List of BRS candidates
May 11, 2024 1:55 PM